Skip to content

13F-HR filed by Tamarack Capital Management, LLC

Tamarack Capital Management, LLC filed this 13F-HR for the quarter ended 2014-06-30, filed 2014-08-15, with 29 holding rows worth $489,890,000.

Accession
0001095449-14-000111
Filed
2014-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2014

A holdings report, 31 entries on the cover page, a total value of $489,890,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $489,894,000 with VALUE read as thousands by filing date, 13F file number 028-15086. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares Russell 2000 ETF464287655SHS1,100,000$128,139,000thousands by filing dateput
CAREFUSION CORP14170T101COM875,000$39,130,000thousands by filing date
VOLCANO CORPORATION928645100COM2,018,300$33,625,000thousands by filing date
ENDOLOGIX INC29266S106COM2,375,000$33,583,000thousands by filing date
SPECTRANETICS CORP84760C107COM1,150,000$26,232,000thousands by filing date
ALKERMES PLCG01767105SHS525,000$25,573,000thousands by filing date
COVIDIEN PLCG2554F113SHS225,000$20,455,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK943,526$18,352,000thousands by filing date
GREATBATCH INC39153L106COM369,900$17,985,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK1,050,000$14,217,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR246,500$13,279,000thousands by filing date
CATAMARAN CORP148887102COM300,000$13,032,000thousands by filing date
MIMEDX GROUP INC602496101COM1,775,000$12,106,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM400,000$11,656,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK800,000$11,512,000thousands by filing date
ATRICURE INC04963C209COM586,555$9,831,000thousands by filing date
RTI BIOLOGICS INC74975N105COM2,150,000$9,353,000thousands by filing date
VOCERA COMMUNICATIONS INC92857F107COMMON STOCK700,000$9,191,000thousands by filing date
PATTERSON COS INC703395103COM225,000$8,858,000thousands by filing date
LUMINEX CORP55027E102COMMON STOCK500,000$8,285,000thousands by filing date
STREAMLINE HEALTH SOLUTIONS86323X106COM1,025,000$5,187,000thousands by filing date
CORIUM INTL INC21887L107COM627,670$4,940,000thousands by filing date
NATUS MEDICAL INC639050103COM153,533$3,797,000thousands by filing date
IMPRIVATA INC45323J103Cmn195,553$3,242,000thousands by filing date
DISCOVERY LABORATORIES INC N254668403COM NEW1,500,000$2,775,000thousands by filing date
CONMED CORP COM207410101Stock50,000$2,178,000thousands by filing date
BIO RAD LABS INC090572207CL A16,369$1,932,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM64,080$1,222,000thousands by filing date
CONMED CORP COM207410101Stock5,200$227,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001095449-14-000111this filing2014-08-15acceptance time not in the bulk data set